Gene Page:RUNX3
概括?
基因 | 864 |
象征 | RUNX3 |
Synonyms | AML2|CBFA3|PEBP2aC |
Description | runt related transcription factor 3 |
Reference | MIM:600210|HGNC:HGNC:10473|Ensembl:ENSG00000020633|HPRD:02565|Vega:OTTHUMG00000003316 |
Gene type | protein-coding |
Map location | 1p36 |
Pascal p-value | 0.317 |
TADA p-value | 0.012 |
Fetal beta | 0.053 |
DMG | 1 (# studies) |
数据源中的基因
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS | |
DMG:vanEijk_2014 | Genome-wide DNA methylation analysis | This dataset includes 432 differentially methylated CpG sites corresponding to 391 unique transcripts between schizophrenia patients (n=260) and unaffected controls (n=250). | 2 |
DNM:Gulsuner_2013 | Whole Exome Sequencing analysis | 155 DNMs identified by exome sequencing of quads or trios of schizophrenia individuals and their parents. |
第一节遗传学和表观遗传学注释
DNM table
Gene | Chromosome | Position | Ref | Alt | Transcript | AA change | Mutation type | 筛 | CG46 | Trait | Study |
---|---|---|---|---|---|---|---|---|---|---|---|
RUNX3 | chr1 | 25233863 | C | T | NM_001031680 NM_004350 |
p.211R>H p.197r> h |
错过 错过 |
精神分裂症 | DNM:Gulsuner_2013 |
Differentially methylated gene
Probe | Chromosome | Position | Nearest gene | P (dis) | Beta (dis) | FDR (dis) | Study |
---|---|---|---|---|---|---|---|
cg06037693 | 1 | 25292072 | RUNX3 | 7.24E-8 | -8.177 | DMG:vanEijk_2014 | |
CG16529592 | 1 | 25292215 | RUNX3 | 2E-6 | -8.26 | DMG:vanEijk_2014 |
Section II. Transcriptome annotation
General gene expression (GTEx)
![Not available](http://www.tjghsg.com/bioinfo/SZGR/GeneImg/RUNX3_DE_GTEx.png)
Gene expression during devlopment (BrainCloud)
脚注:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
Gene expression of temporal and spatial changes (BrainSpan)
脚注:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
Top 10 positively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
LRCH1 | 0.94 | 0.92 |
SSBP2 | 0.94 | 0.89 |
EIF4B | 0.94 | 0.91 |
sema3a | 0.93 | 0.91 |
USP3 | 0.93 | 0.88 |
SLAIN2 | 0.92 | 0.93 |
XRN2 | 0.92 | 0.95 |
PRRC1 | 0.92 | 0.93 |
KDM5B | 0.92 | 0.95 |
C9orf97 | 0.92 | 0.93 |
Top 10 negatively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
LHPP | -0.66 | -0.66 |
TNFSF12 | -0.65 | -0.71 |
C5orf53 | -0.65 | -0.81 |
FBXO2 | -0.65 | -0.70 |
HLA-F | -0.64 | -0.83 |
SERPINB6 | -0.64 | -0.74 |
AIFM3 | -0.64 | -0.82 |
SLC16A11 | -0.63 | -0.70 |
ALDOC | -0.63 | -0.74 |
PTH1R | -0.63 | -0.76 |
第四节。蛋白质蛋白相互作用注释
互动者 | Aliases B | Official full name B | Experimental | 资源 | PubMed ID |
---|---|---|---|---|---|
CBFB | PEBP2B | 核心结合因子,β亚基 | - | HPRD | 7622058 |
CBFB | PEBP2B | 核心结合因子,β亚基 | Cbf-beta interacts with AML2. This interaction was modeled on a demonstrated interaction between mouse Cbf-beta and human AML2. | BIND | 9751710 |
EP300 | kat3b |P300 | E1a结合蛋白p300 | - | HPRD | 15138260 |
HDAC1 | DKFZp686H12203 | GON-10 | HD1 | RPD3 | RPD3L1 | histone deacetylase 1 | - | HPRD | 15138260 |
HDAC2 | RPD3 |yaf1 | histone deacetylase 2 | - | HPRD | 15138260 |
HDAC4 | HA6116 | HD4 | HDAC-A | HDACA | KIAA0288 | histone deacetylase 4 | - | HPRD | 15138260 |
HDAC5 | FLJ90614 | HD5 | NY-CO-9 | histone deacetylase 5 | - | HPRD | 15138260 |
PHB2 | BAP | BCAP37 | Bap37 | MGC117268 | PNAS-141 | REA | p22 | prohibitin 2 | 亲和力捕获ms | BioGRID | 17353931 |
SMAD1 | BSP1 | JV4-1 | JV41 | MADH1 | MADR1 | SMAD family member 1 | Affinity Capture-Western | BioGRID | 10531362 |
SMAD2 | JV18 | JV18-1 | MADH2 | MADR2 | MGC22139 | MGC34440 | hMAD-2 | hSMAD2 | SMAD family member 2 | Affinity Capture-Western | BioGRID | 10531362 |
SMAD3 | DKFZp586N0721 | DKFZp686J10186 | HSPC193 | HsT17436 | JV15-2 | MADH3 | MGC60396 | SMAD family member 3 | - | HPRD | 15138260 |
SMAD3 | DKFZp586N0721 | DKFZp686J10186 | HSPC193 | HsT17436 | JV15-2 | MADH3 | MGC60396 | SMAD family member 3 | Affinity Capture-Western | BioGRID | 10531362 |
SMAD5 | DKFZP781C1895 |DKFZP781O1323 |DWFC |JV5-1 |madh5 | SMAD family member 5 | Affinity Capture-Western | BioGRID | 10531362 |
SMURF1 | KIAA1625 | SMAD specific E3 ubiquitin protein ligase 1 | - | HPRD | 15138260 |
SMURF2 | DKFZp686F0270 | MGC138150 | SMAD specific E3 ubiquitin protein ligase 2 | - | HPRD | 15138260 |
TLE1 | ESG | ESG1 | GRG1 | 分裂1(E(SP1)同源物,果蝇)的透明蛋白样增强剂 | AML2与TLE1相互作用。 | BIND | 9751710 |
TLE1 | ESG | ESG1 | GRG1 | 分裂1(E(SP1)同源物,果蝇)的透明蛋白样增强剂 | - | HPRD,BioGRID | 9751710 |
YAP1 | YAP | YAP2 | YAP65 | YKI | Yes-associated protein 1, 65kDa | Reconstituted Complex | BioGRID | 10228168 |
V.途径注释
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
PID SMAD2 3NUCLEAR PATHWAY | 82 | 63 | 该途径中的所有SZGR 2.0基因 |
通过CD40 UP的Hollmann凋亡 | 201 | 125 | 该途径中的所有SZGR 2.0基因 |
GARY CD5 TARGETS UP | 473 | 314 | 该途径中的所有SZGR 2.0基因 |
CHARAFE BREAST CANCER LUMINAL VS BASAL DN | 455 | 304 | 该途径中的所有SZGR 2.0基因 |
OSMAN BLADDER CANCER UP | 404 | 246 | 该途径中的所有SZGR 2.0基因 |
GINESTIER BREAST CANCER ZNF217 AMPLIFIED DN | 335 | 193 | 该途径中的所有SZGR 2.0基因 |
HOEBEKE LYMPHOID STEM CELL UP | 95 | 64 | 该途径中的所有SZGR 2.0基因 |
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION HSC DN | 187 | 115 | 该途径中的所有SZGR 2.0基因 |
CHOW RASSF1 TARGETS DN | 29 | 19 | 该途径中的所有SZGR 2.0基因 |
GAUSSMANN MLL AF4 FUSION TARGETS B UP | 26 | 16 | 该途径中的所有SZGR 2.0基因 |
LASTOWSKA NEUROBLASTOMA COPY NUMBER DN | 800 | 473 | 该途径中的所有SZGR 2.0基因 |
MUELLER METHYLATED IN GLIOBLASTOMA | 40 | 22 | 该途径中的所有SZGR 2.0基因 |
PEREZ TP63 TARGETS | 355 | 243 | 该途径中的所有SZGR 2.0基因 |
MARTIN INTERACT WITH HDAC | 44 | 31 | 该途径中的所有SZGR 2.0基因 |
Lindgren膀胱癌簇2B | 392 | 251 | 该途径中的所有SZGR 2.0基因 |
dirmeier LMP1响应迟到 | 57 | 41 | 该途径中的所有SZGR 2.0基因 |
AMUNDSON RESPONSE TO ARSENITE | 217 | 143 | 该途径中的所有SZGR 2.0基因 |
LI WILMS TUMOR VS FETAL KIDNEY 2 DN | 51 | 42 | 该途径中的所有SZGR 2.0基因 |
BENPORATH ES CORE NINE CORRELATED | 100 | 68 | 该途径中的所有SZGR 2.0基因 |
AMIT EGF响应60 HELA | 46 | 32 | 该途径中的所有SZGR 2.0基因 |
AMIT EGF响应120 HELA | 69 | 47 | 该途径中的所有SZGR 2.0基因 |
ZHANG TARGETS OF EWSR1 FLI1 FUSION | 88 | 68 | 该途径中的所有SZGR 2.0基因 |
NPM1突变DN的Verhaak AML | 246 | 180 | 该途径中的所有SZGR 2.0基因 |
BROWNE HCMV INFECTION 20HR UP | 240 | 152 | 该途径中的所有SZGR 2.0基因 |
BROWNE HCMV INFECTION 16HR UP | 225 | 139 | 该途径中的所有SZGR 2.0基因 |
BROWNE HCMV INFECTION 48HR UP | 180 | 125 | 该途径中的所有SZGR 2.0基因 |
维萨拉衰老淋巴细胞DN | 19 | 10 | 该途径中的所有SZGR 2.0基因 |
RODWELL AGING KIDNEY UP | 487 | 303 | 该途径中的所有SZGR 2.0基因 |
BILD E2F3 ONCOGENIC SIGNATURE | 246 | 153 | 该途径中的所有SZGR 2.0基因 |
LOPES METHYLATED IN COLON CANCER DN | 28 | 26 | 该途径中的所有SZGR 2.0基因 |
WALLACE PROSTATE CANCER RACE UP | 299 | 167 | 该途径中的所有SZGR 2.0基因 |
CHENG IMPRINTED BY ESTRADIOL | 110 | 68 | 该途径中的所有SZGR 2.0基因 |
ACEVEDO METHYLATED IN LIVER CANCER DN | 940 | 425 | 该途径中的所有SZGR 2.0基因 |
HOQUE METHYLATED IN CANCER | 56 | 45 | 该途径中的所有SZGR 2.0基因 |
SMID BREAST CANCER RELAPSE IN BONE DN | 315 | 197 | 该途径中的所有SZGR 2.0基因 |
乳腺癌萧述三腔的DN | 564 | 326 | 该途径中的所有SZGR 2.0基因 |
Smid乳腺癌正常 | 476 | 285 | 该途径中的所有SZGR 2.0基因 |
SMID BREAST CANCER BASAL UP | 648 | 398 | 该途径中的所有SZGR 2.0基因 |
RUTELLA RESPONSE TO CSF2RB AND IL4 UP | 338 | 225 | 该途径中的所有SZGR 2.0基因 |
RUTELLA RESPONSE TO HGF DN | 235 | 144 | 该途径中的所有SZGR 2.0基因 |
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 DN | 245 | 150 | 该途径中的所有SZGR 2.0基因 |
FINAK BREAST CANCER SDPP SIGNATURE | 26 | 11 | 该途径中的所有SZGR 2.0基因 |
Zhan早期分化基因dn | 42 | 29 | 该途径中的所有SZGR 2.0基因 |
VALK AML CLUSTER 9 | 35 | 26 | 该途径中的所有SZGR 2.0基因 |
JISON SICKLE CELL DISEASE DN | 181 | 97 | 该途径中的所有SZGR 2.0基因 |
ONO AML1 TARGETS DN | 41 | 25 | 该途径中的所有SZGR 2.0基因 |
ono foxp3目标dn | 42 | 23 | 该途径中的所有SZGR 2.0基因 |
FONTAINE PAPILLARY THYROID CARCINOMA DN | 80 | 53 | 该途径中的所有SZGR 2.0基因 |
由PML Rara Fusion绑定的Martens | 456 | 287 | 该途径中的所有SZGR 2.0基因 |
Bruins通过TP53组D的UVC响应 | 280 | 158 | 该途径中的所有SZGR 2.0基因 |
TORCHIA TARGETS OF EWSR1 FLI1 FUSION DN | 321 | 200 | 该途径中的所有SZGR 2.0基因 |
ALFANO MYC TARGETS | 239 | 156 | 该途径中的所有SZGR 2.0基因 |
BOSCO TH1 CYTOTOXIC MODULE | 114 | 62 | 该途径中的所有SZGR 2.0基因 |